- Home
- AAME vs CRVO Comparison
AAME vs CRVO Comparison
Compare AAME & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAME | CRVO |
|---|---|---|
| Founded | 1968 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.7M | 39.3M |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | AAME | CRVO |
|---|---|---|
| Price | $1.71 | $3.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 14.1K | ★ 14.8M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $188,227,000.00 | $4,006,510.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $7.77 | ★ N/A |
| Revenue Growth | ★ 0.77 | N/A |
| 52 Week Low | $1.59 | $2.13 |
| 52 Week High | $3.71 | $13.13 |
Technical Indicators
Market Signals| Indicator | AAME | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 38.94 | 52.56 |
| Support Level | $1.59 | $2.47 |
| Resistance Level | $3.15 | $4.82 |
| Average True Range (ATR) | 0.09 | 0.96 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 28.00 | 21.69 |
Price Performance
Historical ComparisonAbout AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.